Interesting Engineering on MSN2h
US approves first nasal spray for major depressive disorder, PTSD conditionsJohnson & Johnson has announced a major breakthrough in mental health treatment. The Food and Drug Administration (FDA) has approved Spravato, a novel nasal spray, for the standalone treatment of ...
CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...
The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...
People with bipolar disorder may be at a higher risk of developing premenstrual dysphoric disorder (PMDD), but neither condition directly causes the other.
Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback